Daniel Gendron

2.2k total citations
38 papers, 1.7k citations indexed

About

Daniel Gendron is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Daniel Gendron has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Neurology. Recurrent topics in Daniel Gendron's work include RNA Research and Splicing (9 papers), Polyomavirus and related diseases (8 papers) and Viral Infections and Immunology Research (6 papers). Daniel Gendron is often cited by papers focused on RNA Research and Splicing (9 papers), Polyomavirus and related diseases (8 papers) and Viral Infections and Immunology Research (6 papers). Daniel Gendron collaborates with scholars based in Canada, Switzerland and Saudi Arabia. Daniel Gendron's co-authors include Neil R. Cashman, Robert J. Zatorre, Alan C. Evans, Stirling Carpenter, Albert Gjedde, Jeanne Teitelbaum, Elvy Lapointe, Benoı̂t Chabot, Daria A. Trojan and Linda Ofiara and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Daniel Gendron

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Gendron Canada 17 899 295 260 209 205 38 1.7k
Mineo Yasuda Japan 24 673 0.7× 187 0.6× 99 0.4× 34 0.2× 63 0.3× 76 2.2k
Zhiqun Tan United States 23 782 0.9× 207 0.7× 239 0.9× 37 0.2× 75 0.4× 45 1.4k
Peter Chidiac Canada 31 2.7k 3.0× 1.0k 3.4× 239 0.9× 33 0.2× 25 0.1× 75 3.4k
Gary V. Désir United States 36 2.4k 2.7× 212 0.7× 184 0.7× 16 0.1× 53 0.3× 89 3.3k
A. G. Prat United States 19 1.1k 1.2× 308 1.0× 208 0.8× 50 0.2× 18 0.1× 23 1.9k
Edit Hermesz Hungary 20 844 0.9× 263 0.9× 176 0.7× 13 0.1× 20 0.1× 53 1.5k
Rand Posmantur United States 21 1.3k 1.5× 525 1.8× 290 1.1× 7 0.0× 740 3.6× 26 2.4k
Kristin Lorent United States 27 1.2k 1.3× 492 1.7× 872 3.4× 9 0.0× 57 0.3× 44 2.8k
Yaping Wang China 16 388 0.4× 57 0.2× 178 0.7× 80 0.4× 29 0.1× 77 1.1k
T Abe Japan 23 629 0.7× 191 0.6× 307 1.2× 5 0.0× 213 1.0× 83 2.0k

Countries citing papers authored by Daniel Gendron

Since Specialization
Citations

This map shows the geographic impact of Daniel Gendron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Gendron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Gendron more than expected).

Fields of papers citing papers by Daniel Gendron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Gendron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Gendron. The network helps show where Daniel Gendron may publish in the future.

Co-authorship network of co-authors of Daniel Gendron

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Gendron. A scholar is included among the top collaborators of Daniel Gendron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Gendron. Daniel Gendron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gendron, Daniel, et al.. (2017). Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway. PLoS ONE. 12(7). e0180336–e0180336. 8 indexed citations
3.
Bar‐Or, Amit, et al.. (2013). Epidural blood patch in a patient with multiple sclerosis: is it safe?. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 60(5). 479–483. 4 indexed citations
4.
Brosseau, Jean‐Philippe, Jean‐François Lucier, Philippe Thibault, et al.. (2013). Tumor microenvironment–associated modifications of alternative splicing. RNA. 20(2). 189–201. 51 indexed citations
5.
Prinos, Panagiotis, Daniel Garneau, Jean‐François Lucier, et al.. (2011). Alternative splicing of SYK regulates mitosis and cell survival. Nature Structural & Molecular Biology. 18(6). 673–679. 93 indexed citations
6.
Srour, Myriam, Véronique Bolduc, Velina Guergueltcheva, et al.. (2010). DOK7 mutations presenting as a proximal myopathy in French Canadians. Neuromuscular Disorders. 20(7). 453–457. 18 indexed citations
7.
Brosseau, Jean‐Philippe, Jean‐François Lucier, Elvy Lapointe, et al.. (2009). High-throughput quantification of splicing isoforms. RNA. 16(2). 442–449. 70 indexed citations
8.
Venables, Julian P., Roscoe Klinck, Anne Bramard, et al.. (2008). Identification of Alternative Splicing Markers for Breast Cancer. Cancer Research. 68(22). 9525–9531. 140 indexed citations
9.
Gendron, Daniel, Daniel Garneau, Roscoe Klinck, et al.. (2006). Modulation of 5' splice site selection using tailed oligonucleotides carrying splicing signals. BMC Biotechnology. 6(1). 5–5. 18 indexed citations
10.
Bouchard, Louise, Pascale Labrecque, Daniel Gendron, et al.. (2003). Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines.. PubMed. 63(22). 7679–88. 141 indexed citations
11.
Sforza, Émilia, et al.. (2001). Upper Airway Sensation in Snoring and Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 164(2). 250–255. 200 indexed citations
12.
Kingma, John G., et al.. (2001). THE EFFECTS OF HEMODILUTION WITH HEMOLINK™ UPON HEMODYNAMICS AND BLOOD FLOW DISTRIBUTION IN ANESTHETIZED DOGS. Artificial Cells Blood Substitutes and Biotechnology. 29(6). 465–481. 3 indexed citations
13.
Gendron, Daniel, et al.. (2000). Involvement of Minor Structural Proteins in Recombination of Polyoma Virus DNA. Virology. 278(1). 122–132.
14.
Bourgaux-Ramoisy, Danielle, Daniel Gendron, & Pierre Bourgaux. (1995). A hotspot for promoter-dependent recombination inpolyomavirus DNA. Journal of Molecular Biology. 248(2). 220–224. 3 indexed citations
15.
Trojan, Daria A., Daniel Gendron, & Neil R. Cashman. (1994). Macroelectromyography and fiber density in post-poliomyelitis syndrome. Archives of Physical Medicine and Rehabilitation. 75(9). 1026. 1 indexed citations
16.
Trojan, Daria A., Daniel Gendron, & Neil R. Cashman. (1991). ELECTROPHYSIOLOGY AND ELECTRODIAGNOSIS OF THE POST-POLIO MOTOR UNIT. Orthopedics. 14(12). 1353–1361. 75 indexed citations
17.
Teitelbaum, Jeanne, Robert J. Zatorre, Stirling Carpenter, et al.. (1990). Neurologic Sequelae of Domoic Acid Intoxication Due to the Ingestion of Contaminated Mussels. New England Journal of Medicine. 322(25). 1781–1787. 391 indexed citations
18.
So, Norman K., Samuel F. Berkovic, Frédérick Andermann, et al.. (1989). MYOCLONUS EPILEPSY AND RAGGED-RED FIBRES (MERRF). Brain. 112(5). 1261–1276. 96 indexed citations
19.
Gendron, Daniel, Louis Delbecchi, Danielle Bourgaux-Ramoisy, & Pierre Bourgaux. (1988). A substitution in a nonconserved region of polyomavirus large T antigen which causes a thermosensitive mutation. Virology. 165(1). 165–171. 3 indexed citations
20.
Lapierre, Yves, et al.. (1987). Treatment of Spasticity with Tizanidine in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(S3). 513–517. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026